多原发黑色素瘤与恶性肿瘤风险的关联:基于监测、流行病学和最终结果计划数据库1973-2014年数据的人群分析
基于监测、流行病学和最终结果计划数据库1973-2014年数据,分析223799例≥1个原发黑色素瘤、19709例≥2个和3995例≥3个原发黑色素瘤患者。后续内脏恶性肿瘤风险随原发黑色素瘤数量增加而升高,观察与预期比值分别为0.99、1.14、1.23(P<.05)。后续皮肤黑色素瘤风险亦升高,观察与预期比值分别为8.09、22.52、41.03(P<.05)。
要点
- 多原发黑色素瘤患者后续内脏恶性肿瘤风险随原发黑色素瘤数量增加而升高。
- 后续皮肤黑色素瘤风险随原发黑色素瘤数量增加而显著升高。
- 年轻多原发黑色素瘤患者和浅表扩散型黑色素瘤患者内脏恶性肿瘤风险更高。
核心结论
- 多原发黑色素瘤患者后续内脏和皮肤恶性肿瘤风险增加,可能受益于严格遵守年龄特异性癌症筛查。
研究设计与样本
- 基于监测、流行病学和最终结果计划数据库1973-2014年数据的 population-based 分析,分析≥1个、≥2个和≥3个原发黑色素瘤患者的多原发标准化发病比。
主要发现
- 共识别223799例≥1个原发黑色素瘤、19709例≥2个和3995例≥3个原发黑色素瘤患者。
- 后续内脏恶性肿瘤风险随原发黑色素瘤数量增加,≥1个、≥2个和≥3个原发黑色素瘤患者的观察与预期比值分别为0.99、1.14、1.23(P<.05)。
- 年轻多原发黑色素瘤患者和浅表扩散型黑色素瘤患者的内脏恶性肿瘤风险更高。
- 多原发黑色素瘤患者中最常见的内脏恶性肿瘤包括乳腺、前列腺、甲状腺、软组织、脑、肾、非霍奇金淋巴瘤和慢性淋巴细胞白血病。
- 后续皮肤黑色素瘤风险随原发黑色素瘤数量增加,≥1个、≥2个和≥3个原发黑色素瘤患者的观察与预期比值分别为8.09、22.52、41.03(P<.05)。
临床怎么用
- 作者认为多原发黑色素瘤患者可能受益于严格遵守年龄特异性癌症筛查。
局限性
- 监测、流行病学和最终结果计划记录中关于色素表型、组织学和治疗的信息有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPMs). We hypothesized that individuals with MPMs might have an increased incidence of internal malignancies. OBJECTIVE: To identify the risk for subsequent malignancies in MPM patients. METHODS: Multiple primary standardized incidence ratios were analyzed for individuals with ≥1, ≥2 and ≥3 primary melanomas (PMs) recorded in the Surveillance, Epidemiology, and End Results database during 1973-2014. RESULTS: We identified 223,799 individuals with ≥1 PM, 19,709 with ≥2 PMs, and 3,995 with ≥3 PMs. Risks of subsequent internal malignancy increased with number of PMs, with observed:expected ratios of 0.99, 1.14, and 1.23 (P < .05) for patients with ≥1 PM, ≥2 PMs, and ≥3 PMs, respectively. Internal malignancy was higher in younger MPM patients and those with superficial spreading melanoma. The most common malignancies among MPM patients included breast, prostate, thyroid, soft tissue, brain, kidney, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. Risk for subsequent cutaneous melanoma increased with observed:expected ratios of 8.09, 22.52, 41.03 (P < .05) for patients with ≥1 PM, ≥2 PMs, and ≥3 PMs, respectively. LIMITATIONS: Surveillance, Epidemiology, and End Results records limited information about pigmentation phenotypes, histology, and treatments. CONCLUSION: Patients with MPMs have an increased risk for subsequent internal and cutaneous malignancies and might benefit from tight adherence to age-specific cancer screening.
引用
- Cai ED, Swetter SM, Sarin KY, et al. Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014. J Am Acad Dermatol. 2018. PMID: 30287320. doi:10.1016/j.jaad.2018.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。